2seventy bio, Inc. (TSVT) Reports In-Line Q3 EPS

2seventy bio, Inc. (NASDAQ: TSVT) reported Q3 EPS of ($0.19), in-line with the analyst estimate of ($0.19). Revenue for the quarter came in at $13.53 million versus the consensus estimate of $16.18 million.

For earnings history and earnings-related data on 2seventy bio, Inc. (TSVT) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• St. James's Place plc (STJ:LN) (STJPF) PT Raised to GBP20.50 at Deutsche Bank
• Goldman Sachs Assumes Klaviyo Inc (KVYO) at Buy